US Patent Issued to The Regents of the University of California, Dainton Biosciences on Feb. 17 for "Small molecules targeting the intrinsically disordered structural ensemble of Alpha-synuclein protect against diverse Alpha-synuclein mediated dysfunctions" (California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,889, issued on Feb. 17, was assigned to The Regents of the University of California (Oakland, Calif.) and Dainton Biosciences LLC (Burlingame, Calif.).

"Small molecules targeting the intrinsically disordered structural ensemble of Alpha-synuclein protect against diverse Alpha-synuclein mediated dysfunctions" was invented by Lisa McConlogue (Oakland, Calif.) and David A. Agard (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are pharmaceutical compositions and methods for treatment or prevention of synucleinopathies with small-molecule inhibitors of pathogenic Alpha-synuclein activity having the Formula (I). Also, provi...